Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Alimera Sciences Inc (ALIM)

1.22 0.06 (5.17%)

01-23 16:00

Open:

1.17

Pre. Close:

1.16

High:

1.22

Low:

1.155

Volume:

166,523

Market Cap:

84M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.222 - 1.229

1.229 - 1.235

Low:

1.132 - 1.141

1.141 - 1.149

Close:

1.207 - 1.22

1.22 - 1.232

Technical analysis  (as of: 2018-01-23 4:21:49 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 1.49     One year: 1.61

Support:

Support1: 1.11    Support2: 0.92

Resistance:

Resistance1: 1.28    Resistance2: 1.38

Pivot:

1.27

Moving Averages:

MA(5): 1.21     MA(20): 1.29

MA(100): 1.31     MA(250): 1.37

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 26.60     %D(3): 19.78

RSI:

RSI(14): 40.71

52-Week:

High: 1.72  Low: 1.11  Change(%): 4.3

Average Vol(K):

3-Month: 16885  10-Days 21295

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ALIM has closed above bottom band by 24.2%. Bollinger Bands are 63.3% wider than normal. The large width of the bands suggest high volatility as compared to ALIM's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Wed, 25 Oct 2017 17:26:15 GMT
Alimera Sciences to Report Third Quarter 2017 Results November 1st, 2017

Mon, 08 Jan 2018 12:22:30 GMT
Alimera Sciences Refinances Debt With New $40 Million Debt Facility From Solar ...

Mon, 11 Dec 2017 12:22:30 GMT
Alimera Sciences Announces Patients Now Being Treated With ILUVIEN® In Ireland

Tue, 25 Jul 2017 20:03:45 GMT
Alimera Sciences Announces Real-World Audit Data Supporting the Positive ...

Tue, 07 Nov 2017 12:22:30 GMT
Alimera Sciences' CEO Dan Myers to Present During Ophthalmology Innovation ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

69.15

Shares Float (M)

68.35

% Held by Insiders

1.20

% Held by Institutions

65.00

Shares Short (K)

754

Shares Short Prior Month (K)

682

Stock Financials

EPS

-0.280

EPS Est. Current Year

-0.210

EPS Est. Next Year

-0.080

EPS Est. Next Quarter

-0.020

Forward EPS

-0.090

Book Value (p.s.)

12.980

PEG Ratio

Profit Margin

-55.20

Operating Margin

-42.94

Return on Assets (ttm)

-29.6

Return on Equity (ttm)

47.7

Qtrly Rev. Growth

17.9

Gross Profit (p.s.)

0.494

Sales Per Share

EBITDA (p.s.)

-0.193

Qtrly Earnings Growth

Operating Cash Flow (M)

-13.57

Levered Free Cash Flow (M)

-3.97

atoplab.com

Valuation

P/E

-4.36

P/E Growth Ratio

0.05

P/BV

0.09

P/S

148005264.00

P/CF

-6.22

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.